- Home
- VYNE vs RPID Comparison
VYNE vs RPID Comparison
Compare VYNE & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- RPID
- Stock Information
- Founded
- VYNE 2003
- RPID 2006
- Country
- VYNE United States
- RPID United States
- Employees
- VYNE N/A
- RPID N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- RPID Medical Specialities
- Sector
- VYNE Health Care
- RPID Health Care
- Exchange
- VYNE Nasdaq
- RPID Nasdaq
- Market Cap
- VYNE 41.9M
- RPID 37.3M
- IPO Year
- VYNE 2018
- RPID 2021
- Fundamental
- Price
- VYNE $2.90
- RPID $1.10
- Analyst Decision
- VYNE Strong Buy
- RPID
- Analyst Count
- VYNE 2
- RPID 0
- Target Price
- VYNE $6.88
- RPID N/A
- AVG Volume (30 Days)
- VYNE 122.3K
- RPID 114.2K
- Earning Date
- VYNE 11-07-2024
- RPID 11-01-2024
- Dividend Yield
- VYNE N/A
- RPID N/A
- EPS Growth
- VYNE N/A
- RPID N/A
- EPS
- VYNE N/A
- RPID N/A
- Revenue
- VYNE $493,000.00
- RPID $26,170,000.00
- Revenue This Year
- VYNE $32.31
- RPID $24.34
- Revenue Next Year
- VYNE N/A
- RPID $19.49
- P/E Ratio
- VYNE N/A
- RPID N/A
- Revenue Growth
- VYNE 39.27
- RPID 27.31
- 52 Week Low
- VYNE $1.57
- RPID $0.58
- 52 Week High
- VYNE $4.09
- RPID $1.34
- Technical
- Relative Strength Index (RSI)
- VYNE 59.02
- RPID 55.12
- Support Level
- VYNE $2.65
- RPID $1.01
- Resistance Level
- VYNE $3.05
- RPID $1.19
- Average True Range (ATR)
- VYNE 0.23
- RPID 0.11
- MACD
- VYNE -0.05
- RPID -0.02
- Stochastic Oscillator
- VYNE 34.57
- RPID 30.30
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.